Research ArticleClinical Studies

Hysterectomy for Recurrent/Residual Cervical Cancer Following Definitive Radiotherapy

TADAHARU NAKASONE, YUSUKE TAIRA, YUKO SHIMOJI, YOSHIHISA ARAKAKI, TOMOKO NAKAMOTO, TAKUMA OOYAMA, WATARU KUDAKA, ITOMI KANESHIMA, KUMIKO NISHIHIRA, KEIKO MEKARU and YOICHI AOKI
In Vivo July 2020, 34 (4) 2173-2177; DOI: https://doi.org/10.21873/invivo.12026

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Kaplan-Meier curves for OS and DFS in the study population (N=21). The 5-year OS and DFS rates were 51.9% and 50.1%, respectively. OS: Overall survival; DFS: disease-free survival.

  • Figure 2.
    Figure 2.

    Kaplan-Meier curves for OS and DFS according to histological response (Ef 1 vs. Ef 2 or Ef 3). The 5-year OS was 88.9% in Ef 2 or Ef 3 patients and 22.5% in Ef 1 patients. The 5-year DFS was 78.8% in Ef 2 or Ef 3 patients and 24.2% in Ef 1 patients.

Tables

  • Table I.
  • Table II.
  • Table III.
  • Table IV.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Hysterectomy for Recurrent/Residual Cervical Cancer Following Definitive Radiotherapy
TADAHARU NAKASONE, YUSUKE TAIRA, YUKO SHIMOJI, YOSHIHISA ARAKAKI, TOMOKO NAKAMOTO, TAKUMA OOYAMA, WATARU KUDAKA, ITOMI KANESHIMA, KUMIKO NISHIHIRA, KEIKO MEKARU, YOICHI AOKI
In Vivo Jul 2020, 34 (4) 2173-2177; DOI: 10.21873/invivo.12026
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords